Longleaf Partners Fund Exits Bio-Rad (BIO)
The Longleaf Partners Fund underperformed in Q2 2026 with a return of 3.87%, lagging behind the S&P 500 and Russell 1000 Value Index. The fund exited its position in Bio-Rad Laboratories (BIO) during this period, despite initiating one new healthcare investment.
Tickers: $BIO
Topics: Bio-Rad Laboratories, Inc. Longleaf Partners Fund Russell 1000 Value Index S&P 500